RenovoRx

James McComb
Jan 11, 2021
1 min read

Updated: Feb 18, 2021

Oculus Advisors advised a family office on its growth capital investment in RenovoRX, a medical device and drug company headquartered in Silicon Valley. RenovoRX is in Phase III trials for a proprietary treatment platform, initially targeting pancreatic cancer

Oculus Advisors is an investor in RenovoRX

Sponsor: Family Office and Oculus Advisors

Recent Posts

See All

VideoTaxi

In August 2021, Oculus Advisors invested alongside management in VideoTaxi, an industry-leading, independent producer of video content...

Trident Royalties

$US10 million senior secured loan facility into an Australian subsidiary of Trident Royalties Plc, a UK-listed entity that owns a number...

Eversholt Rail

A consortium comprising STAR Capital, 3i Infrastructure and Morgan Stanley Infrastructure acquired Eversholt, one of the three largest...

この投稿へのコメントは利用できなくなりました。詳細はサイト所有者にお問い合わせください。